| Primary |
| Multiple Sclerosis |
67.0% |
| Relapsing-remitting Multiple Sclerosis |
15.5% |
| Depression |
2.4% |
| Pain |
2.4% |
| Hypertension |
2.1% |
| Multiple Sclerosis Relapse |
1.1% |
| Muscle Spasticity |
1.1% |
| Insomnia |
1.0% |
| Muscle Spasms |
0.9% |
| Fatigue |
0.9% |
| Headache |
0.8% |
| Migraine |
0.7% |
| Anxiety |
0.7% |
| Hypothyroidism |
0.7% |
| Gastrooesophageal Reflux Disease |
0.5% |
| Sleep Disorder |
0.5% |
| Contraception |
0.5% |
| Neuralgia |
0.4% |
| Constipation |
0.4% |
| Back Pain |
0.3% |
|
| Fatigue |
13.5% |
| Nausea |
7.5% |
| Headache |
6.9% |
| Visual Impairment |
6.8% |
| White Blood Cell Count Decreased |
6.6% |
| Vision Blurred |
6.1% |
| Heart Rate Decreased |
5.6% |
| Dizziness |
5.0% |
| Multiple Sclerosis Relapse |
4.9% |
| Somnolence |
4.7% |
| Vomiting |
4.1% |
| Pain In Extremity |
3.4% |
| Pain |
3.3% |
| Dyspnoea |
3.3% |
| Urinary Tract Infection |
3.2% |
| Visual Acuity Reduced |
3.2% |
| Hypoaesthesia |
3.1% |
| Paraesthesia |
2.9% |
| Palpitations |
2.9% |
| Pyrexia |
2.9% |
|
| Secondary |
| Multiple Sclerosis |
47.4% |
| Relapsing-remitting Multiple Sclerosis |
17.6% |
| Depression |
6.3% |
| Hypertension |
5.6% |
| Product Used For Unknown Indication |
3.4% |
| Muscle Spasticity |
2.7% |
| Pain |
2.7% |
| Fatigue |
1.8% |
| Muscle Spasms |
1.6% |
| Multiple Sclerosis Relapse |
1.4% |
| Migraine |
1.3% |
| Hypothyroidism |
1.1% |
| Anxiety |
1.0% |
| Contraception |
1.0% |
| Supplementation Therapy |
0.9% |
| Constipation |
0.9% |
| Neuralgia |
0.9% |
| Sleep Disorder |
0.9% |
| Back Pain |
0.8% |
| Nausea |
0.8% |
|
| Visual Impairment |
10.0% |
| White Blood Cell Count Decreased |
9.7% |
| Vision Blurred |
7.2% |
| Fatigue |
6.9% |
| Urinary Tract Infection |
6.1% |
| Multiple Sclerosis Relapse |
5.3% |
| Dyspnoea |
5.0% |
| Headache |
4.7% |
| Overdose |
4.7% |
| Vomiting |
4.7% |
| Weight Decreased |
4.7% |
| Dizziness |
4.4% |
| Palpitations |
4.4% |
| Nausea |
3.9% |
| Suicide Attempt |
3.6% |
| Pyrexia |
3.3% |
| Chest Pain |
3.0% |
| Somnolence |
3.0% |
| Rash |
2.8% |
| Central Nervous System Lesion |
2.5% |
|
| Concomitant |
| Multiple Sclerosis |
67.6% |
| Product Used For Unknown Indication |
12.9% |
| Relapsing-remitting Multiple Sclerosis |
2.7% |
| Diabetes Mellitus |
2.2% |
| Depression |
2.0% |
| Multiple Sclerosis Relapse |
1.7% |
| Pain |
1.2% |
| Gait Disturbance |
1.0% |
| Insomnia |
1.0% |
| Asthma |
0.8% |
| Back Pain |
0.8% |
| Mental Disorder |
0.8% |
| Muscle Spasticity |
0.8% |
| Fatigue |
0.7% |
| Hypertension |
0.7% |
| Neuralgia |
0.7% |
| Premedication |
0.7% |
| Supplementation Therapy |
0.7% |
| Restless Legs Syndrome |
0.5% |
| Sexual Dysfunction |
0.5% |
|
| Multiple Sclerosis Relapse |
19.0% |
| Drug Ineffective |
7.1% |
| Pain |
6.3% |
| Fatigue |
5.6% |
| Progressive Multifocal Leukoencephalopathy |
5.6% |
| Memory Impairment |
4.8% |
| Multiple Sclerosis |
4.8% |
| Nausea |
4.8% |
| Visual Impairment |
4.8% |
| Weight Increased |
4.8% |
| Death |
4.0% |
| Headache |
4.0% |
| Rash |
4.0% |
| Convulsion |
3.2% |
| Hypersensitivity |
3.2% |
| Immune Reconstitution Syndrome |
3.2% |
| Pneumonia |
3.2% |
| Vomiting |
3.2% |
| Hypoaesthesia |
2.4% |
| Mobility Decreased |
2.4% |
|
| Interacting |
| Multiple Sclerosis |
23.5% |
| Relapsing-remitting Multiple Sclerosis |
22.1% |
| Multiple Sclerosis Relapse |
7.4% |
| Contraception |
5.9% |
| Headache |
5.9% |
| Hypersensitivity |
5.9% |
| Hypertension |
5.9% |
| Product Used For Unknown Indication |
5.9% |
| Depression |
4.4% |
| Neuralgia |
2.9% |
| Mental Retardation |
1.5% |
| Mild Mental Retardation |
1.5% |
| Neuropathy Peripheral |
1.5% |
| Oral Contraception |
1.5% |
| Pain |
1.5% |
| Paraesthesia |
1.5% |
| Psychopathic Personality |
1.5% |
|
| Drug Interaction |
16.7% |
| Abnormal Sensation In Eye |
6.7% |
| Dyspnoea |
6.7% |
| Headache |
6.7% |
| Nasopharyngitis |
6.7% |
| Sleep Disorder |
6.7% |
| Vomiting |
6.7% |
| Alopecia |
3.3% |
| Blood Albumin Decreased |
3.3% |
| Cardiac Arrest |
3.3% |
| Chills |
3.3% |
| Death |
3.3% |
| Depression |
3.3% |
| Electrocardiogram Qt Prolonged |
3.3% |
| Heart Rate Decreased |
3.3% |
| Herpes Zoster |
3.3% |
| Inappropriate Schedule Of Drug Administration |
3.3% |
| Lymphocyte Count Decreased |
3.3% |
| Multiple Sclerosis Relapse |
3.3% |
| Nasal Septum Deviation |
3.3% |
|
